norethindrone and HIV Coinfection

norethindrone has been researched along with HIV Coinfection in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.86)	18.2507
2000's	6 (17.14)	29.6817
2010's	25 (71.43)	24.3611
2020's	3 (8.57)	2.80

Authors

Authors	Studies
Ackerman, P; Clark, A; Mageau, AS; Magee, M; Mannino, F; Moore, K; Nwokolo, N; Post, E; Shah, R	1
Aceves, KM; Cherpes, TL; Gabriel, JM; Hatfield, AM; Kaur, B; Kwiek, JJ; Quispe Calla, NE; Torres, AR; Trout, W; Vicetti Miguel, RD	1
Balle, C; Barnabas, SL; Bekker, LG; Bosinger, SE; Brodie, E; Esra, R; Gamieldien, H; Gill, K; Happel, AU; Havyarimana, E; Jaspan, HB; Jaumdally, SZ; Karaoz, U; Konstantinus, IN; Lennard, K; Maseko, V; Moodie, Z; Myer, L; Passmore, JS; Pidwell, T	1
Baeten, JM; Balkus, JE; Brown, ER; Chappell, C; Harkoo, I; Jeenarain, N; Kabwigu, S; Kintu, K; Kiweewa, FM; Marzinke, M; Naidoo, L; Nair, G; Nakabiito, C; Palanee-Phillips, T; Reddy, K; Siva, S; Soto-Torres, L	1
Achilles, SL; Dorflinger, LJ; Hapgood, JP; Heffron, R; Kiarie, J; Polis, CB; Steyn, PS	1
Avenant, C; Dlamini, S; Hapgood, JP; Maritz, MF; Ray, RM; Tomasicchio, M; van der Spuy, Z	1
Hallett, T; McCoy, SI; Padian, N; Ralph, LJ	1
Curtis, KM; Polis, CB	1
Atrio, J; Cherala, G; Kovacs, A; Mishell, DR; Neely, M; Stanczyk, FZ	1
Cates, W	1
Gollub, EL; Stein, Z	1
Redd, AD	1
Hallett, T; McCoy, S; Padian, N; Ralph, L	1
Avenant, C; Govender, Y; Hapgood, JP; Ray, RM; Tomasicchio, M	1
Cooney, R; Hayward, P	1
Curtis, KM; Hannaford, P; Phillips, SJ; Polis, CB; Raymond, E; Steyn, PS; Turner, AN; Westreich, DJ	1
Baeten, JM; Brown, J; Chen, PL; Crook, AM; Delany-Moretlwe, S; Francis, SC; Friedland, BA; Hayes, RJ; Heffron, R; Kapiga, S; Karim, QA; Karpoff, S; Kaul, R; Kwok, C; Low, N; McClelland, RS; McCormack, S; McGrath, N; Morrison, CS; Myer, L; Rees, H; Stalter, R; Van Damme, L; van de Wijgert, JH; van der Straten, A; Watson-Jones, D	1
Baeten, JM; Balkus, JE; Bunge, K; Chirenje, ZM; Gomez, K; Hillier, SL; Marrazzo, JM; Nair, G; Noguchi, LM; Palanee-Phillips, T; Parikh, UM; Piper, JM; Ramjee, G; Richardson, BA; Selepe, P; van der Straten, A; Watts, DH	1
Abdellati, S; Agot, K; Ahmed, K; Cohen, M; Crucitti, T; Deese, J; Masson, L; Miller, W; Morrison, C; Van Damme, L; Wang, M	1
Jones, HE; van de Wijgert, JH	2
Averbach, S; Darney, P; Seidman, D; Smith-McCune, K	1
Hofmeyr, GJ; Lawrie, TA; Singata, M; Temmerman, M	1
Balkus, JE; Marrazzo, JM; Noguchi, LM; Richardson, BA	1
Schooling, CM	1
Gollub, EL; Jones, HE; Ralph, LJ	1
McCormack, S; Ramjee, G	1
Dorflinger, L; Halpern, V; Schivone, G	1
Clark, RA; Theall, K	1
Catanzaro, LM; Morse, GD	1
Heard, I	1
Denny, L; Kuhn, L; Myer, L; Wright, TC	1
Delany, S; Dinat, N; Kleinschmidt, I; McIntyre, JA; Nkala, B; Rees, H; Smith, D	1
Hutman, HW; Lamson, M; Marshak, A; McDonough, M; Mildvan, D; Robinson, P; Yarrish, R	1

Reviews

7 review(s) available for norethindrone and HIV Coinfection

Article	Year
Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. The Lancet. Infectious diseases, 2013, Volume: 13, Issue:9 Topics: Aniline Compounds; Condoms, Female; Contraception; Contraceptives, Oral, Hormonal; Databases, Factual; Female; HIV Infections; Humans; Maternal Mortality; Norethindrone; Pregnancy; Pregnancy Rate; Reproducibility of Results; Risk Factors	2013
Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis. American journal of reproductive immunology (New York, N.Y. : 1989), 2014, Volume: 71, Issue:6 Topics: Africa South of the Sahara; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Receptors, Glucocorticoid	2014
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception, 2014, Volume: 90, Issue:4 Topics: Administration, Oral; Africa; Condoms; Contraceptive Agents, Female; Female; HIV Infections; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone	2014
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS medicine, 2015, Volume: 12, Issue:1 Topics: Adolescent; Adult; Africa South of the Sahara; Contraceptive Agents, Female; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Risk Factors	2015
Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data. Current opinion in obstetrics & gynecology, 2015, Volume: 27, Issue:6 Topics: Adult; Contraceptive Agents, Female; Female; Health Knowledge, Attitudes, Practice; Health Priorities; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Public Health; Risk Assessment; Risk Factors; Sexual Behavior	2015
Injectable contraception: updates and innovation. Current opinion in obstetrics & gynecology, 2016, Volume: 28, Issue:6 Topics: Abortion, Induced; Adult; Contraception; Contraceptive Agents, Female; Drug Delivery Systems; Family Planning Services; Female; Health Services Accessibility; HIV Infections; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Pregnancy; Pregnancy, Unplanned; Risk	2016
Data from clinical trials. Journal of acquired immune deficiency syndromes (1999), 2005, Volume: 38 Suppl 1 Topics: Anti-HIV Agents; Clinical Trials as Topic; Contraceptives, Oral, Hormonal; Databases, Factual; Drug Interactions; Ethinyl Estradiol; Female; HIV Infections; Humans; Norethindrone	2005

Trials

7 trial(s) available for norethindrone and HIV Coinfection

Article	Year
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co-administration. HIV medicine, 2023, Volume: 24, Issue:5 Topics: Adult; Anti-HIV Agents; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; HIV Infections; Humans; Norethindrone; Pharmaceutical Preparations; Progestins	2023
Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial. Nature communications, 2020, 11-04, Volume: 11, Issue:1 Topics: Adolescent; Africa South of the Sahara; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Cytokines; Female; HIV Infections; Hormonal Contraception; Humans; Microbiota; Norethindrone; RNA, Ribosomal, 16S; T-Lymphocytes; Vagina; Young Adult	2020
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception. Journal of acquired immune deficiency syndromes (1999), 2017, 10-01, Volume: 76, Issue:2 Topics: Adolescent; Adult; Anti-Retroviral Agents; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pregnancy; Pyrimidines; Young Adult	2017
Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women. Journal of acquired immune deficiency syndromes (1999), 2014, Jan-01, Volume: 65, Issue:1 Topics: Adult; Contraceptives, Oral, Synthetic; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Norethindrone	2014
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. The lancet. HIV, 2015, Volume: 2, Issue:7 Topics: Adult; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Proportional Hazards Models; Risk Factors; South Africa; Tenofovir; Young Adult	2015
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. International journal of epidemiology, 2007, Volume: 36, Issue:1 Topics: Adult; Age Distribution; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Prospective Studies; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases; South Africa; Time Factors; Uterine Cervical Neoplasms	2007
Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women. Journal of acquired immune deficiency syndromes (1999), 2002, Apr-15, Volume: 29, Issue:5 Topics: Adult; Anti-HIV Agents; Area Under Curve; Contraceptives, Oral, Combined; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; HIV Infections; Humans; Middle Aged; Nevirapine; Norethindrone; Reverse Transcriptase Inhibitors	2002

Other Studies

21 other study(ies) available for norethindrone and HIV Coinfection

Article	Year
Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1. ImmunoHorizons, 2020, 02-11, Volume: 4, Issue:2 Topics: Animals; Contraceptive Agents, Female; Desmoglein 1; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, SCID; Mucous Membrane; Norethindrone; Permeability; Vagina	2020
Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women. Contraception, 2019, Volume: 99, Issue:4 Topics: Contraceptive Agents, Hormonal; Disease Susceptibility; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone	2019
The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations. Scientific reports, 2019, 03-13, Volume: 9, Issue:1 Topics: Cervix Uteri; Contraceptive Agents, Hormonal; Dose-Response Relationship, Drug; Female; HEK293 Cells; HIV Infections; HIV-1; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Receptors, CCR5; Risk Factors; RNA, Messenger; Virus Replication	2019
Next steps for research on hormonal contraception and HIV. Lancet (London, England), 2013, Nov-02, Volume: 382, Issue:9903 Topics: Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic; Risk Assessment	2013
Research on hormonal contraception and HIV. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic	2014
Research on hormonal contraception and HIV. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic	2014
Research on hormonal contraception and HIV. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic	2014
Research on hormonal contraception and HIV - Authors' reply. Lancet (London, England), 2014, Jan-25, Volume: 383, Issue:9914 Topics: Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic	2014
Highlights from the 21st CROI. The Lancet. Infectious diseases, 2014, Volume: 14, Issue:4 Topics: Animals; Anti-HIV Agents; Child; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis C; HIV Infections; Humans; Infant, Newborn; Male; Medication Adherence; Medroxyprogesterone Acetate; Norethindrone	2014
Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract. American journal of reproductive immunology (New York, N.Y. : 1989), 2015, Volume: 74, Issue:4 Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Cytokines; Female; Genitalia, Female; HIV Infections; Humans; Inflammation; Kenya; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginosis, Bacterial; Young Adult	2015
DMPA use and HIV acquisition: time to switch to NET-EN? The lancet. HIV, 2015, Volume: 2, Issue:7 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply. The lancet. HIV, 2015, Volume: 2, Issue:9 Topics: Contraception Behavior; Contraceptive Agents, Female; Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Norethindrone	2015
The role of progestins in HIV acquisition in young women. The Lancet. Infectious diseases, 2016, Volume: 16, Issue:4 Topics: Female; HIV Infections; Humans; Norethindrone; Progestins; Risk Factors	2016
Population-based study evaluating association between selected antiretroviral therapies and potential oral contraceptive failure. Journal of acquired immune deficiency syndromes (1999), 2004, Sep-01, Volume: 37, Issue:1 Topics: Anti-HIV Agents; Contraception; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Female; HIV Infections; Humans; Norethindrone; Reverse Transcriptase Inhibitors; Treatment Failure	2004
Data from the French cohort studies and framing the French contraceptive guidelines. Journal of acquired immune deficiency syndromes (1999), 2005, Volume: 38 Suppl 1 Topics: Anti-HIV Agents; Cohort Studies; Contraception; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; France; HIV Infections; Humans; Male; Norethindrone; Practice Guidelines as Topic	2005
Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception, 2007, Volume: 75, Issue:6 Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Family Planning Services; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone; Norethindrone; Prevalence; South Africa	2007
Recruitment underway for oral contraceptive trial. AIDS patient care and STDs, 1998, Volume: 12, Issue:5 Topics: Anti-HIV Agents; Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Mestranol; Nevirapine; Norethindrone; Patient Selection	1998